SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019605
Filing Date
2023-05-09
Accepted
2023-05-09 16:02:28
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q idya-20230331.htm   iXBRL 10-Q 2969718
2 EX-31.1 idya-ex31_1.htm EX-31 19808
3 EX-31.2 idya-ex31_2.htm EX-31 19326
4 EX-32.1 idya-ex32_1.htm EX-32 16554
  Complete submission text file 0000950170-23-019605.txt   8587172

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idya-20230331_def.xml EX-101.DEF 176433
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idya-20230331.xsd EX-101.SCH 49734
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idya-20230331_lab.xml EX-101.LAB 422100
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idya-20230331_pre.xml EX-101.PRE 304535
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT idya-20230331_cal.xml EX-101.CAL 38505
57 EXTRACTED XBRL INSTANCE DOCUMENT idya-20230331_htm.xml XML 1354396
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 23901807
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences